ARIES - Ambrisentan in Patients With Moderate to Severe Pulmonary Arterial Hypertension (PAH)

PHASE3CompletedINTERVENTIONAL
Enrollment

372

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

February 28, 2006

Study Completion Date

February 28, 2006

Conditions
Pulmonary Hypertension
Interventions
DRUG

Ambrisentan

Trial Locations (46)

2010

St. Vincent's Hospital, Sydney

10029

Mt. Sinai Medical Center, New York

10032

New York Presbyterian Hospital, New York

11030

Northshore University/Long Island Jewish Hospital, Manhasset

11501

Winthrop University Hospital, Mineola

13210

Cardiology PC, Syracuse

15213

University of Pittsburgh Medical Center, Pittsburgh

19104

University of Pennsylvania Hospital, Philadelphia

21205

Johns Hopkins University, Baltimore

22908

University of Virginia Health System, Charlottesville

23298

Virginia Commonwealth University, Richmond

30322

Emory University Hospital, Atlanta

30912

Medical College of Georgia, Augusta

33140

Mt. Sinai Medical Center, Miami

37232

Vanderbilt University Medical Center, Nashville

44106

University Hospitals of Cleveland, Cleveland

44195

Cleveland Clinic Foundation, Cleveland

45219

Lindner Clinical Trial Center, Cincinnati

48109

University of Michigan Medical Center, Ann Arbor

48201

Wayne State University, Detroit

52242

University of Iowa Hospitals and Clinics, Iowa City

53215

Heart Care Associates, Milwaukee

55905

Mayo Clinic, Rochester

60153

Loyola University Medical Center, Chicago

63110

Washington University, St Louis

70121

Ochsner Clinic, New Orleans

75235

St. Paul Hospital, Dallas

76508

Scott & White Hospital, Temple

77030

Baylor College of Medicine, Houston

78229

University of Texas - San Antonio, San Antonio

80021

Myogen, Westminster

80262

University of Colorado Health Sciences Center, Denver

85006

Pulmonary Associates, PA, Phoenix

85013

Arizona Pulmonary Specialists, Phoenix

90073

Brentwood Biomedical Research Institute, Los Angeles

90502

Los Angeles County Harbor-UCLA Medical Center, Torrance

92037

University of California San Diego Medical Center, San Diego

95817

University of California-Davis, Sacramento

97202

Oregon Health Sciences University, Portland

06030

University of Connecticut Health Center, Farmington

04102

Maine Medical Center, Portland

02111

Tufts New England Medical Center, Boston

02114

Massachusetts General Hospital, Boston

02115

Brigham and Women's Hospital, Boston

02903

Rhode Island Hospital, Providence

H3T1E2

Jewish General Hospital, Montreal

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Gilead Sciences

INDUSTRY

NCT00091598 - ARIES - Ambrisentan in Patients With Moderate to Severe Pulmonary Arterial Hypertension (PAH) | Biotech Hunter | Biotech Hunter